Understand the source comparison
GABAergic vs Serotonergic Pathways: Core Mechanistic Divergence
Selank operates through the GABAergic system. The brain's primary inhibitory network. GABA-A receptors are ligand-gated chloride channels that hyperpolarize neurons when activated, reducing excitability across cortical and limbic circuits. Selank doesn't bind
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Selank operates through the GABAergic system. The brain's primary inhibitory network. GABA-A receptors are ligand-gated chloride channels that hyperpolarize neurons when activated, reducing excitability across cortical and limbic circuits. Selank doesn't bind to GABA-A receptors directly like benzodiazepines do; instead, it modulates receptor subunit gene expression through tuftsin-derived peptide sequences. Research published in the Journal of Psychopharmacology demonstrated that selank administration increases mRNA levels for GABA-A receptor α2 and α3 subunits by 35–50% within 72 hours, enhancing the receptor's sensitivity to endogenous GABA without exogenous agonism. This upregulation occurs without the compensatory downregulation seen with chronic benzodiazepine use.
- Lexapro targets the serotonergic system through SERT inhibition. The serotonin transporter is responsible for clearing serotonin from the synaptic cleft after neurotransmission. Blocking it causes serotonin to accumulate, prolonging receptor activation. Lexapro binds to SERT with high affinity (Ki = 0.8 nM), occupying approximately 80% of transporter sites at therapeutic doses (10–20 mg daily). The immediate result is elevated synaptic serotonin, but the anxiolytic effect requires downstream adaptation: 5-HT1A autoreceptor desensitization in the raphe nuclei, which takes 2–4 weeks. Until autoreceptors stop inhibiting serotonin neuron firing, the net serotonergic tone doesn't increase enough to produce clinical benefit. This delay is why SSRIs require weeks to work despite immediate SERT blockade.
- The mechanistic consequence: selank acts on the system that directly inhibits neural firing (GABAergic), while Lexapro acts on a system that modulates mood and arousal through complex receptor feedback loops (serotonergic). One is immediate GABAergic enhancement through receptor expression changes; the other is delayed serotonergic augmentation through transporter blockade and autoreceptor adaptation. We've found that understanding this distinction explains why onset profiles, side effect patterns, and discontinuation experiences differ so dramatically between these compounds.